Olympus

What Olympus does

Olympus Corporation is a Japanese multinational medical technology company founded in 1919 and headquartered in Tokyo, listed on the Tokyo Stock Exchange. The company specializes in optical and digital precision technology with a primary focus on medical endoscopy, endoluminal robotics, and related therapeutic devices. Its product portfolio centers on the EVIS X1 Endoscopy System, the EZ1500 series of endoscopes featuring proprietary Extended Depth of Field (EDOF) imaging, the EndoTherapy portfolio for therapeutic endoscopic interventions, and the Odin Medical CADDIE cloud-based AI platform for computer-aided detection in endoscopy. The company also distributes robot-assisted endoscopy technologies through an exclusive global partnership with EndoRobotics (announced 2026-05-05, with initial U.S. rollout).

Olympus serves hospitals, clinics, and surgical specialty centers performing gastrointestinal, urological (cystoscopy), ENT, and other minimally invasive procedures for the diagnosis and treatment of early-stage cancers and precancerous lesions. The company generates revenue through a combination of one-time capital equipment sales of endoscopy systems and a recurring revenue stream from consumables, service contracts, and maintenance tied to its installed base. Go-to-market combines direct enterprise sales teams targeting hospital systems with channel partnerships leveraging its global commercial infrastructure across Japan, North America (Center Valley, PA regional HQ and Canada subsidiary), and Europe. Named strategic customers include healthcare providers broadly and Photocure ASA, which installed 60 Visera Elite III BLC systems across Europe for bladder cancer diagnostics. The company employs 10,000+ people globally and is currently executing a restructuring plan under CEO Bob White that includes approximately 2,000 job cuts (roughly 7% of workforce) and a supply chain review in response to higher U.S. tariffs and a voluntary PolyLoop product recall.

Name

Olympus

Legal name

Olympus Corporation

Website

https://heylink.me

Company type

Public

Founded year

1919

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Olympus Corporation is a Japanese medical technology company that develops and sells endoscopy systems, endoluminal robotics, AI-augmented diagnostic tools, and related consumables to hospitals and surgical centers for minimally invasive gastrointestinal and urological procedures.

Ownership category

akta.pro rank

Product category

Medical Endoscopy Equipment

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industries

Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN), Endoscopy & GI Diagnostic Centers (HLAFAKAG), Reprocessing & Endoscope Infection Prevention (AERs, Drying/Storage, Leak Testing, Brushes) (HLAHANAJ)

Keywords

• Medical endoscopy equipment
• Surgical imaging systems
• Endoluminal robotics
• Minimally invasive devices
• Endoscopic therapy products

Headquarters

HQ city

Shinjuku

HQ country

Japan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Medical Endoscopy Equipment Sales: Olympus generates revenue from selling endoscopy systems, endoscopes, and related medical equipment to hospitals and healthcare providers globally.
2. Endoscopy Services and Consumables: Ongoing revenue from service contracts, maintenance, and consumable products for installed base of endoscopy equipment including tower systems and imaging platforms.
3. Strategic Technology Partnerships: Revenue opportunities through distribution partnerships and collaborations that expand Olympus product portfolio without direct R&D investment.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Olympus manufactures and sells medical endoscopy systems, endoscopes, and related therapeutic devices for hospitals and healthcare providers. Its portfolio includes advanced imaging platforms such as the EVIS X1 system, EZ1500 series endoscopes with Extended Depth of Field technology, and the EndoTherapy portfolio for treating early-stage gastrointestinal cancers and precancerous lesions. The company also distributes robot-assisted endoscopy technologies through a global partnership with EndoRobotics.

Differentiator

Problem solved

Functional benefit

Products and services

• EVIS X1 Endoscopy System Advanced endoscopy platform with integrated imaging technologies for gastrointestinal examinations, designed for hospitals and gastroenterology departments performing diagnostic and therapeutic endoscopic procedures.
• EZ1500 Series Endoscopes with Extended Depth of Field (EDOF) Endoscopes featuring Extended Depth of Field imaging technology designed to improve image sharpness and visibility during gastrointestinal examinations; targeted at gastroenterologists and endoscopy suites.
• Visera Elite III BLC Endoscopy imaging system used for bladder cancer diagnostics with Photocure's Hexvix/Cysview procedures; installed at healthcare institutions across Europe.
• EndoTherapy Portfolio Comprehensive portfolio of endoscopic therapy products and robot-assisted endoscopy technologies for treating early-stage cancers and precancerous lesions of the gastrointestinal tract.
• CADDIE (Odin Medical AI) FDA-cleared cloud-based AI deployment platform for computer-aided detection during endoscopic procedures; supports improved lesion detection and diagnostic accuracy in gastroenterology.

Quantifiable outcome

• Expanded access to endoscopic procedures for early-stage cancers through global distribution partnership
• +1 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• EndoRobotics Co., Ltd.coreChannel Partner/ Reseller/ Distributor · 5 May 2026Olympus signed an exclusive global distribution agreement with EndoRobotics to distribute robot-assisted endoscopy technologies worldwide as part of its EndoTherapy portfolio. The partnership aims to broaden patient access to endoscopic procedures for treating early-stage cancers and precancerous lesions of the gastrointestinal tract. Initial market rollout began in the United States, leveraging Olympus' global commercial infrastructure.
• ZEISScoreStrategic or Co-development Partner · 1 January 2025Strategic collaboration between Olympus and ZEISS as part of FluoGuide's partnerships for surgical guidance technology. The collaboration indicates Olympus' involvement in advanced surgical imaging and visualization technologies.
• EndoclotminorStrategic or Co-development Partner · 1 May 2023Olympus extended its partnership with US-based medical device company Endoclot to introduce hemostatic agents supporting safer gastrointestinal procedures. The collaboration supports Olympus' endotherapy portfolio with complementary products for endoscopic interventions.
• Odin MedicalcoreTechnology or Integration · 1 January 2023Odin Medical, part of Olympus, received FDA clearance for CADDIE - a cloud-based AI deployment for endoscopy. This represents internal technology development/integration supporting Olympus' AI-enhanced endoscopy capabilities.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Smith+Nephew: Medical device incumbent with sports medicine, ENT, and advanced surgical visualization offerings; overlaps with Olympus' surgical specialty center and ENT endoscopy use cases.
• Stryker: Large diversified medical device company with surgical visualization, ENT, and minimally invasive surgery portfolios that overlap with Olympus' endoscopy and ENT specialty surgical offerings.
• Medtronic: Global medtech incumbent with a GI and endoscopy franchise (GI Genius AI, PillCam) competing with Olympus across endoscopic diagnostics and AI-assisted detection.
• Johnson & Johnson (Ethicon / Auris Health): Through Ethicon and Auris Health (Monarch platform), J&J competes in minimally invasive and robotic-assisted endoscopic procedures, positioning it as a broad incumbent rival to Olympus' therapeutic endoscopy roadmap.

Direct peers

• KARL STORZ: German family-owned manufacturer of endoscopes and visualization systems for human and veterinary medicine. Directly competes with Olympus across rigid and flexible endoscopy, including the cystoscopes market where both are leading players.
• Boston Scientific: Global medical device company with significant endoscopy and urology franchises, including single-use and reusable scopes and therapeutic devices. Co-leads the cystoscopes market with Olympus and overlaps on GI endotherapy products.
• Fujifilm Healthcare: Operates a healthcare division that markets endoscopy systems, including the ELUXEO platform, directly competing with Olympus' EVIS X1 in GI endoscopy. Also offers AI-enabled endoscopy solutions.
• Pentax Medical (HOYA): HOYA Corporation's medical division develops and sells flexible endoscopy systems, therapeutic accessories, and AI-assisted endoscopy tools, directly competing with Olympus in GI and ENT endoscopy globally.
• Taewoong Medical: South Korea-based manufacturer of GI endoscopy accessories, including stents and therapeutic devices, acquired by Olympus in 2023 to expand its GI endotherapy portfolio — now an in-house capability rather than an independent peer.

Emerging players

• Intuitive Surgical: Leader in robotic-assisted surgery with the da Vinci platform. As Olympus expands into robot-assisted endoscopy through its EndoRobotics partnership, Intuitive is the dominant incumbent it must compete against in the robotic therapeutic space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Olympus